Neuromeka Announces 122.6 Billion KRW Rights Offering and 0.5-for-1 Stock Dividend, Diluting Existing Shareholders by 25.76%
The company will issue 3,196,465 new common shares via a rights offering at an anticipated price of 38,350 KRW, approximately 21% below the current market price. Total proceeds of about 122.6 billion KRW will be used for facility investment 76.0 billion, working capital 36.6 billion, and debt repayment 10.0 billion.
After the rights offering, a 0.5-for-1 stock dividend will be distributed to existing shareholders, increasing total shares from 12,409,151 to approximately 23.41 million.
Subscription rights certificates will be listed on the Korea Exchange, and the offering is underwritten by Korea Investment & Securities, NH Investment & Securities, and Samsung Securities.
[AI Summary]The 25.76% dilution and discounted issuance significantly impair existing shareholder value. While most funds are allocated to facility and operating capital to support growth, the massive share increase may pressure the stock price in the near term.
KOSDAQ Filing Information
[Correction of Description] Report On Major Events (Decision On Paid-In And Free Capital Increase)